| Year |
Citation |
Score |
| 2024 |
Brevini TAL, Pennarossa G, Antonini S, Paffoni A, Tettamanti G, Montemurro T, Radaelli E, Lazzari L, Rebulla P, Scanziani E, de Eguileor M, Benvenisty N, Ragni G, Gandolfi F. Editorial Expression of Concern: Cell Lines Derived from Human Parthenogenetic Embryos Can Display Aberrant Centriole Distribution and Altered Expression Levels of Mitotic Spindle Check-point Transcripts. Stem Cell Reviews and Reports. PMID 39180682 DOI: 10.1007/s12015-024-10779-3 |
0.331 |
|
| 2023 |
Pagis A, Alfi O, Kinreich S, Yilmaz A, Hamdan M, Gadban A, Panet A, Wolf DG, Benvenisty N. Genome-wide loss-of-function screen using human pluripotent stem cells to study virus-host interactions for SARS-CoV-2. Stem Cell Reports. 18: 1766-1774. PMID 37703821 DOI: 10.1016/j.stemcr.2023.07.003 |
0.328 |
|
| 2023 |
Ludwig TE, Andrews PW, Barbaric I, Benvenisty N, Bhattacharyya A, Crook JM, Daheron LM, Draper JS, Healy LE, Huch M, Inamdar MS, Jensen KB, Kurtz A, Lancaster MA, Liberali P, et al. ISSCR standards for the use of human stem cells in basic research. Stem Cell Reports. 18: 1744-1752. PMID 37703820 DOI: 10.1016/j.stemcr.2023.08.003 |
0.37 |
|
| 2023 |
Viner-Breuer R, Golan-Lev T, Benvenisty N, Goldberg M. Genome-Wide Screening in Human Embryonic Stem Cells Highlights the Hippo Signaling Pathway as Granting Synthetic Viability in ATM Deficiency. Cells. 12. PMID 37296624 DOI: 10.3390/cells12111503 |
0.311 |
|
| 2023 |
Haim-Abadi G, Golan-Lev T, Koren A, Benvenisty N. Generation, genomic characterization, and differentiation of triploid human embryonic stem cells. Stem Cell Reports. PMID 37116485 DOI: 10.1016/j.stemcr.2023.04.001 |
0.459 |
|
| 2023 |
Keshet G, Bar S, Sarel-Gallily R, Yanuka O, Benvenisty N, Eldar-Geva T. Differentiation of uniparental human embryonic stem cells into granulosa cells reveals a paternal contribution to gonadal development. Stem Cell Reports. PMID 37001516 DOI: 10.1016/j.stemcr.2023.03.004 |
0.456 |
|
| 2022 |
Andrews PW, Barbaric I, Benvenisty N, Draper JS, Ludwig T, Merkle FT, Sato Y, Spits C, Stacey GN, Wang H, Pera MF. The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells. Cell Stem Cell. 29: 1624-1636. PMID 36459966 DOI: 10.1016/j.stem.2022.11.006 |
0.379 |
|
| 2022 |
Lezmi E, Benvenisty N. The Tumorigenic Potential of Human Pluripotent Stem Cells. Stem Cells Translational Medicine. PMID 35679163 DOI: 10.1093/stcltm/szac039 |
0.385 |
|
| 2022 |
Sarel-Gallily R, Golan-Lev T, Yilmaz A, Sagi I, Benvenisty N. Genome-wide analysis of haploinsufficiency in human embryonic stem cells. Cell Reports. 38: 110573. PMID 35354027 DOI: 10.1016/j.celrep.2022.110573 |
0.374 |
|
| 2022 |
Rozanska A, Cerna-Chavez R, Queen R, Collin J, Zerti D, Dorgau B, Beh CS, Davey T, Coxhead J, Hussain R, Al-Aama J, Steel DH, Benvenisty N, Armstrong L, Parulekar M, et al. pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation. Stem Cells Translational Medicine. 11: 415-433. PMID 35325233 DOI: 10.1093/stcltm/szac008 |
0.368 |
|
| 2021 |
Bar S, Vershkov D, Keshet G, Lezmi E, Meller N, Yilmaz A, Yanuka O, Nissim-Rafinia M, Meshorer E, Eldar-Geva T, Benvenisty N. Identifying regulators of parental imprinting by CRISPR/Cas9 screening in haploid human embryonic stem cells. Nature Communications. 12: 6718. PMID 34795250 DOI: 10.1038/s41467-021-26949-7 |
0.388 |
|
| 2021 |
Keshet G, Benvenisty N. Large-scale analysis of imprinting in naive human pluripotent stem cells reveals recurrent aberrations and a potential link to FGF signaling. Stem Cell Reports. 16: 2520-2533. PMID 34597600 DOI: 10.1016/j.stemcr.2021.09.002 |
0.414 |
|
| 2021 |
Braverman-Gross C, Benvenisty N. Modeling Maturity Onset Diabetes of the Young in Pluripotent Stem Cells: Challenges and Achievements. Frontiers in Endocrinology. 12: 622940. PMID 33692757 DOI: 10.3389/fendo.2021.622940 |
0.312 |
|
| 2021 |
Avior Y, Eggan K, Benvenisty N. Retraction Notice to: Cancer-Related Mutations Identified in Primed and Naive Human Pluripotent Stem Cells. Cell Stem Cell. 28: 173. PMID 33433329 DOI: 10.1016/j.stem.2020.11.020 |
0.325 |
|
| 2020 |
Avior Y, Lezmi E, Eggan K, Benvenisty N. Cancer-Related Mutations Identified in Primed Human Pluripotent Stem Cells. Cell Stem Cell. PMID 33321073 DOI: 10.1016/j.stem.2020.11.013 |
0.324 |
|
| 2020 |
Bar S, Benvenisty N. Human pluripotent stem cells: derivation and applications. Nature Reviews. Molecular Cell Biology. PMID 33154591 DOI: 10.1038/s41580-020-00309-7 |
0.42 |
|
| 2020 |
Yilmaz A, Braverman-Gross C, Bialer-Tsypin A, Peretz M, Benvenisty N. Mapping Gene Circuits Essential for Germ Layer Differentiation via Loss-of-Function Screens in Haploid Human Embryonic Stem Cells. Cell Stem Cell. PMID 32735778 DOI: 10.1016/J.Stem.2020.06.023 |
0.504 |
|
| 2020 |
Lezmi E, Weissbein U, Golan-Lev T, Nissim-Rafinia M, Meshorer E, Benvenisty N. The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation. Stem Cell Reports. PMID 32559458 DOI: 10.1016/J.Stemcr.2020.05.014 |
0.484 |
|
| 2019 |
Viner-Breuer R, Yilmaz A, Benvenisty N, Goldberg M. The essentiality landscape of cell cycle related genes in human pluripotent and cancer cells. Cell Division. 14: 15. PMID 31889988 DOI: 10.1186/S13008-019-0058-4 |
0.508 |
|
| 2019 |
Avior Y, Eggan K, Benvenisty N. Cancer-Related Mutations Identified in Primed and Naive Human Pluripotent Stem Cells. Cell Stem Cell. 25: 456-461. PMID 31543368 DOI: 10.1016/J.Stem.2019.09.001 |
0.375 |
|
| 2019 |
Sagi I, De Pinho JC, Zuccaro MV, Atzmon C, Golan-Lev T, Yanuka O, Prosser R, Sadowy A, Perez G, Cabral T, Glaser B, Tsang SH, Goland R, Sauer MV, Lobo R, ... Benvenisty N, et al. Distinct Imprinting Signatures and Biased Differentiation of Human Androgenetic and Parthenogenetic Embryonic Stem Cells. Cell Stem Cell. 25: 419-432.e9. PMID 31491396 DOI: 10.1016/J.Stem.2019.06.013 |
0.485 |
|
| 2019 |
Yilmaz A, Benvenisty N. Defining Human Pluripotency. Cell Stem Cell. 25: 9-22. PMID 31271751 DOI: 10.1016/J.Stem.2019.06.010 |
0.57 |
|
| 2019 |
Bar S, Benvenisty N. Epigenetic aberrations in human pluripotent stem cells. The Embo Journal. PMID 31088843 DOI: 10.15252/Embj.2018101033 |
0.524 |
|
| 2019 |
Kim JH, Alderton A, Benvenisty N, Brandsten C, Firpo M, Harrison PW, Kawamata S, Kawase E, Kurtz A, Loring JF, Ludwig T, Man J, Mountford JC, Turner ML, Oh S, et al. A report from a workshop of the International Stem Cell Banking Initiative, held in collaboration GAiT and the Harvard Stem Cell Institute, Boston 2017. Stem Cells (Dayton, Ohio). PMID 31021472 DOI: 10.1002/Stem.3003 |
0.501 |
|
| 2019 |
Bar S, Seaton LR, Weissbein U, Eldar-Geva T, Benvenisty N. Global Characterization of X Chromosome Inactivation in Human Pluripotent Stem Cells. Cell Reports. 27: 20-29.e3. PMID 30943402 DOI: 10.1016/J.Celrep.2019.03.019 |
0.42 |
|
| 2019 |
Vershkov D, Fainstein N, Suissa S, Golan-Lev T, Ben-Hur T, Benvenisty N. FMR1 Reactivating Treatments in Fragile X iPSC-Derived Neural Progenitors In Vitro and In Vivo. Cell Reports. 26: 2531-2539.e4. PMID 30840878 DOI: 10.1016/J.Celrep.2019.02.026 |
0.409 |
|
| 2019 |
Weissbein U, Peretz M, Plotnik O, Yanuka O, Sagi I, Golan-Lev T, Benvenisty N. Genome-wide Screen for Culture Adaptation and Tumorigenicity-Related Genes in Human Pluripotent Stem Cells. Iscience. 11: 398-408. PMID 30660107 DOI: 10.1016/J.Isci.2018.12.031 |
0.427 |
|
| 2018 |
Sagi I, Bar S, Benvenisty N. Mice from Same-Sex Parents: CRISPRing Out the Barriers for Unisexual Reproduction. Cell Stem Cell. 23: 625-627. PMID 30388415 DOI: 10.1016/J.Stem.2018.10.012 |
0.42 |
|
| 2018 |
Braverman-Gross C, Nudel N, Ronen D, Beer NL, McCarty MI, Benvenisty N. Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs. Stem Cell Research. 31: 16-26. PMID 29990710 DOI: 10.1016/J.Scr.2018.06.013 |
0.449 |
|
| 2018 |
Yilmaz A, Peretz M, Aharony A, Sagi I, Benvenisty N. Defining essential genes for human pluripotent stem cells by CRISPR-Cas9 screening in haploid cells. Nature Cell Biology. PMID 29662178 DOI: 10.1038/S41556-018-0088-1 |
0.492 |
|
| 2017 |
Weissbein U, Plotnik O, Vershkov D, Benvenisty N. Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells. Plos Genetics. 13: e1006979. PMID 28837588 DOI: 10.1371/Journal.Pgen.1006979 |
0.502 |
|
| 2017 |
Andrews PW, Ben-David U, Benvenisty N, Coffey P, Eggan K, Knowles BB, Nagy A, Pera M, Reubinoff B, Rugg-Gunn PJ, Stacey GN. Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications. Stem Cell Reports. 9: 1-4. PMID 28700896 DOI: 10.1016/J.Stemcr.2017.05.029 |
0.496 |
|
| 2017 |
Sagi I, Benvenisty N. Haploidy in Humans: An Evolutionary and Developmental Perspective. Developmental Cell. 41: 581-589. PMID 28633015 DOI: 10.1016/J.Devcel.2017.04.019 |
0.489 |
|
| 2017 |
Bar S, Schachter M, Eldar-Geva T, Benvenisty N. Large-Scale Analysis of Loss of Imprinting in Human Pluripotent Stem Cells. Cell Reports. 19: 957-968. PMID 28467909 DOI: 10.1016/J.Celrep.2017.04.020 |
0.549 |
|
| 2017 |
Merkle FT, Ghosh S, Kamitaki N, Mitchell J, Avior Y, Mello C, Kashin S, Mekhoubad S, Ilic D, Charlton M, Saphier G, Handsaker RE, Genovese G, Bar S, Benvenisty N, et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature. PMID 28445466 DOI: 10.1038/Nature22312 |
0.437 |
|
| 2017 |
Avior Y, Lezmi E, Yanuka D, Benvenisty N. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells. Stem Cell Reports. PMID 28392220 DOI: 10.1016/J.Stemcr.2017.03.005 |
0.509 |
|
| 2016 |
Espinosa-Jeffrey A, Blanchi B, Biancotti JC, Kumar S, Hirose M, Mandefro B, Talavera-Adame D, Benvenisty N, de Vellis J. Efficient Generation of Viral and Integration-Free Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes. Current Protocols in Stem Cell Biology. 39: 2D.18.1-2D.18.28. PMID 31816188 DOI: 10.1002/Cpsc.19 |
0.502 |
|
| 2016 |
Sagi I, Benvenisty N. Stem cells: Aspiring to naivety. Nature. PMID 27919070 DOI: 10.1038/Nature20484 |
0.548 |
|
| 2016 |
Vershkov D, Benvenisty N. Human pluripotent stem cells in modeling human disorders: the case of fragile X syndrome. Regenerative Medicine. PMID 27900874 DOI: 10.2217/Rme-2016-0100 |
0.47 |
|
| 2016 |
Yilmaz A, Peretz M, Sagi I, Benvenisty N. Haploid Human Embryonic Stem Cells: Half the Genome, Double the Value. Cell Stem Cell. 19: 569-572. PMID 27814478 DOI: 10.1016/J.Stem.2016.10.009 |
0.48 |
|
| 2016 |
Sagi I, Egli D, Benvenisty N. Identification and propagation of haploid human pluripotent stem cells. Nature Protocols. 11: 2274-2286. PMID 27763625 DOI: 10.1038/Nprot.2016.145 |
0.558 |
|
| 2016 |
Halevy T, Biancotti JC, Yanuka O, Golan-Lev T, Benvenisty N. Molecular Characterization of Down Syndrome Embryonic Stem Cells Reveals a Role for RUNX1 in Neural Differentiation. Stem Cell Reports. PMID 27618722 DOI: 10.1016/J.Stemcr.2016.08.003 |
0.502 |
|
| 2016 |
Halevy T, Akov S, Bohndorf M, Mlody B, Adjaye J, Benvenisty N, Goldberg M. Chromosomal Instability and Molecular Defects in Induced Pluripotent Stem Cells from Nijmegen Breakage Syndrome Patients. Cell Reports. PMID 27545893 DOI: 10.1016/J.Celrep.2016.07.071 |
0.484 |
|
| 2016 |
Espinosa-Jeffrey A, Blanchi B, Biancotti JC, Kumar S, Hirose M, Mandefro B, Talavera-Adame D, Benvenisty N, de Vellis J. Efficient Generation of Viral and Integration-Free Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes. Current Protocols in Stem Cell Biology. 38: 2D.18.1-2D.18.27. PMID 27532816 DOI: 10.1002/Cpsc.11 |
0.502 |
|
| 2016 |
Weissbein U, Schachter M, Egli D, Benvenisty N. Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq. Nature Communications. 7: 12144. PMID 27385103 DOI: 10.1038/Ncomms12144 |
0.388 |
|
| 2016 |
Kimmelman J, Hyun I, Benvenisty N, Caulfield T, Heslop HE, Murry CE, Sipp D, Studer L, Sugarman J, Daley GQ. Policy: Global standards for stem-cell research. Nature. 533: 311-3. PMID 27193661 DOI: 10.1038/533311A |
0.419 |
|
| 2016 |
Daley GQ, Hyun I, Apperley JF, Barker RA, Benvenisty N, Bredenoord AL, Breuer CK, Caulfield T, Cedars MI, Frey-Vasconcells J, Heslop HE, Jin Y, Lee RT, McCabe C, Munsie M, et al. Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines. Stem Cell Reports. PMID 27185282 DOI: 10.1016/J.Stemcr.2016.05.001 |
0.396 |
|
| 2016 |
Kimmelman J, Heslop HE, Sugarman J, Studer L, Benvenisty N, Caulfield T, Hyun I, Murry CE, Sipp D, Daley GQ. New ISSCR guidelines: clinical translation of stem cell research. Lancet (London, England). PMID 27179752 DOI: 10.1016/S0140-6736(16)30390-7 |
0.406 |
|
| 2016 |
Sagi I, Chia G, Golan-Lev T, Peretz M, Weissbein U, Sui L, Sauer MV, Yanuka O, Egli D, Benvenisty N. Derivation and differentiation of haploid human embryonic stem cells. Nature. PMID 26982723 DOI: 10.1038/Nature17408 |
0.577 |
|
| 2016 |
Avior Y, Sagi I, Benvenisty N. Pluripotent stem cells in disease modelling and drug discovery. Nature Reviews. Molecular Cell Biology. PMID 26818440 DOI: 10.1038/Nrm.2015.27 |
0.46 |
|
| 2015 |
De Los Angeles A, Ferrari F, Xi R, Fujiwara Y, Benvenisty N, Deng H, Hochedlinger K, Jaenisch R, Lee S, Leitch HG, Lensch MW, Lujan E, Pei D, Rossant J, Wernig M, et al. Corrigendum: Hallmarks of pluripotency. Nature. PMID 26675727 DOI: 10.1038/Nature16470 |
0.4 |
|
| 2015 |
Lamm N, Ben-David U, Golan-Lev T, Storchová Z, Benvenisty N, Kerem B. Genomic Instability in Human Pluripotent Stem Cells Arises from Replicative Stress and Chromosome Condensation Defects. Cell Stem Cell. PMID 26669899 DOI: 10.1016/J.Stem.2015.11.003 |
0.407 |
|
| 2015 |
Park CY, Halevy T, Lee DR, Sung JJ, Lee JS, Yanuka O, Benvenisty N, Kim DW. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons. Cell Reports. PMID 26440889 DOI: 10.1016/J.Celrep.2015.08.084 |
0.474 |
|
| 2015 |
De Los Angeles A, Ferrari F, Xi R, Fujiwara Y, Benvenisty N, Deng H, Hochedlinger K, Jaenisch R, Lee S, Leitch HG, Lensch MW, Lujan E, Pei D, Rossant J, Wernig M, et al. Hallmarks of pluripotency. Nature. 525: 469-78. PMID 26399828 DOI: 10.1038/Nature15515 |
0.525 |
|
| 2015 |
Weissbein U, Benvenisty N. rsPSCs: A new type of pluripotent stem cells. Cell Research. PMID 26077383 DOI: 10.1038/Cr.2015.73 |
0.506 |
|
| 2015 |
Avior Y, Biancotti JC, Benvenisty N. TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas. Stem Cell Reports. 4: 967-74. PMID 26070610 DOI: 10.1016/J.Stemcr.2015.05.006 |
0.569 |
|
| 2015 |
Stelzer Y, Bar S, Bartok O, Afik S, Ronen D, Kadener S, Benvenisty N. Differentiation of human parthenogenetic pluripotent stem cells reveals multiple tissue- and isoform-specific imprinted transcripts. Cell Reports. 11: 308-20. PMID 25843718 DOI: 10.1016/J.Celrep.2015.03.023 |
0.517 |
|
| 2015 |
Halevy T, Czech C, Benvenisty N. Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells. Stem Cell Reports. 4: 37-46. PMID 25483109 DOI: 10.1016/J.Stemcr.2014.10.015 |
0.323 |
|
| 2015 |
Ben-David U, Cowell IG, Austin CA, Benvenisty N. Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha. Stem Cells (Dayton, Ohio). 33: 1013-9. PMID 25377277 DOI: 10.1002/Stem.1888 |
0.514 |
|
| 2014 |
Johannesson B, Sagi I, Gore A, Paull D, Yamada M, Golan-Lev T, Li Z, LeDuc C, Shen Y, Stern S, Xu N, Ma H, Kang E, Mitalipov S, Sauer MV, ... ... Benvenisty N, et al. Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. Cell Stem Cell. 15: 634-42. PMID 25517467 DOI: 10.1016/J.Stem.2014.10.002 |
0.556 |
|
| 2014 |
Weissbein U, Ben-David U, Benvenisty N. Virtual karyotyping reveals greater chromosomal stability in neural cells derived by transdifferentiation than those from stem cells. Cell Stem Cell. 15: 687-91. PMID 25479746 DOI: 10.1016/J.Stem.2014.10.018 |
0.52 |
|
| 2014 |
Ben-David U, Arad G, Weissbein U, Mandefro B, Maimon A, Golan-Lev T, Narwani K, Clark AT, Andrews PW, Benvenisty N, Carlos Biancotti J. Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells. Nature Communications. 5: 4825. PMID 25198699 DOI: 10.1038/Ncomms5825 |
0.567 |
|
| 2014 |
Ronen D, Benvenisty N. Sex-dependent gene expression in human pluripotent stem cells. Cell Reports. 8: 923-32. PMID 25127145 DOI: 10.1016/J.Celrep.2014.07.013 |
0.476 |
|
| 2014 |
Ludwig G, Nejman D, Hecht M, Orlanski S, Abu-Remaileh M, Yanuka O, Sandler O, Marx A, Roberts D, Benvenisty N, Bergman Y, Mendelsohn M, Cedar H. Aberrant DNA methylation in ES cells. Plos One. 9: e96090. PMID 24852222 DOI: 10.1371/Journal.Pone.0096090 |
0.448 |
|
| 2014 |
Stelzer Y, Sagi I, Yanuka O, Eiges R, Benvenisty N. The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome. Nature Genetics. 46: 551-7. PMID 24816254 DOI: 10.1038/Ng.2968 |
0.466 |
|
| 2014 |
Yamada M, Johannesson B, Sagi I, Burnett LC, Kort DH, Prosser RW, Paull D, Nestor MW, Freeby M, Greenberg E, Goland RS, Leibel RL, Solomon SL, Benvenisty N, Sauer MV, et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature. 510: 533-6. PMID 24776804 DOI: 10.1038/Nature13287 |
0.538 |
|
| 2014 |
Ben-David U, Biran A, Scaffidi P, Herold-Mende C, Boehringer M, Meshorer E, Benvenisty N. Elimination of undifferentiated cancer cells by pluripotent stem cell inhibitors. Journal of Molecular Cell Biology. 6: 267-9. PMID 24683201 DOI: 10.1093/Jmcb/Mju012 |
0.462 |
|
| 2014 |
Ben-David U, Benvenisty N. Chemical ablation of tumor-initiating human pluripotent stem cells. Nature Protocols. 9: 729-40. PMID 24577362 DOI: 10.1038/Nprot.2014.050 |
0.462 |
|
| 2014 |
Weissbein U, Benvenisty N, Ben-David U. Quality control: Genome maintenance in pluripotent stem cells. The Journal of Cell Biology. 204: 153-63. PMID 24446481 DOI: 10.1083/Jcb.201310135 |
0.387 |
|
| 2014 |
Ben-David U, Benvenisty N. Analyzing the genomic integrity of stem cells Stembook. PMID 23658973 DOI: 10.3824/Stembook.1.150.1 |
0.459 |
|
| 2013 |
Nissenbaum J, Bar-Nur O, Ben-David E, Benvenisty N. Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells. Stem Cell Reports. 1: 509-17. PMID 24371806 DOI: 10.1016/J.Stemcr.2013.11.007 |
0.494 |
|
| 2013 |
Stelzer Y, Sagi I, Benvenisty N. Involvement of parental imprinting in the antisense regulation of onco-miR-372-373. Nature Communications. 4: 2724. PMID 24201333 DOI: 10.1038/Ncomms3724 |
0.343 |
|
| 2013 |
Stelzer Y, Ronen D, Bock C, Boyle P, Meissner A, Benvenisty N. Identification of novel imprinted differentially methylated regions by global analysis of human-parthenogenetic-induced pluripotent stem cells. Stem Cell Reports. 1: 79-89. PMID 24052944 DOI: 10.1016/J.Stemcr.2013.03.005 |
0.478 |
|
| 2013 |
Bruck T, Yanuka O, Benvenisty N. Human pluripotent stem cells with distinct X inactivation status show molecular and cellular differences controlled by the X-Linked ELK-1 gene. Cell Reports. 4: 262-70. PMID 23871667 DOI: 10.1016/J.Celrep.2013.06.026 |
0.526 |
|
| 2013 |
Ben-David U, Nudel N, Benvenisty N. Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Nature Communications. 4: 1992. PMID 23778593 DOI: 10.1038/Ncomms2992 |
0.555 |
|
| 2013 |
Ben-David U, Nissenbaum J, Benvenisty N. New balance in pluripotency: reprogramming with lineage specifiers. Cell. 153: 939-40. PMID 23706730 DOI: 10.1016/J.Cell.2013.04.051 |
0.413 |
|
| 2013 |
Ben-David U, Mayshar Y, Benvenisty N. Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles. Nature Protocols. 8: 989-97. PMID 23619890 DOI: 10.1038/Nprot.2013.051 |
0.517 |
|
| 2013 |
Ben-David U, Gan QF, Golan-Lev T, Arora P, Yanuka O, Oren YS, Leikin-Frenkel A, Graf M, Garippa R, Boehringer M, Gromo G, Benvenisty N. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell. 12: 167-79. PMID 23318055 DOI: 10.1016/J.Stem.2012.11.015 |
0.483 |
|
| 2013 |
Benvenisty N. Safety issues in human pluripotent stem cells Toxicology Letters. 221: S9. DOI: 10.1016/J.Toxlet.2013.06.031 |
0.484 |
|
| 2013 |
Mayshar Y, Benvenisty N. Genetic Manipulation of Human Embryonic Stem Cells Handbook of Stem Cells. 1: 327-337. DOI: 10.1016/B978-0-12-385942-6.00026-3 |
0.4 |
|
| 2012 |
Ronen D, Benvenisty N. Genomic stability in reprogramming. Current Opinion in Genetics & Development. 22: 444-9. PMID 23040504 DOI: 10.1016/J.Gde.2012.09.003 |
0.437 |
|
| 2012 |
Sharon N, Mor I, Zahavi E, Benvenisty N. DUXO, a novel double homeobox transcription factor, is a regulator of the gastrula organizer in human embryonic stem cells. Stem Cell Research. 9: 261-9. PMID 23010573 DOI: 10.1016/J.Scr.2012.08.003 |
0.47 |
|
| 2012 |
Pick M, Ronen D, Yanuka O, Benvenisty N. Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 30: 2700-8. PMID 22987393 DOI: 10.1002/Stem.1242 |
0.493 |
|
| 2012 |
Biancotti JC, Narwani K, Mandefro B, Golan-Lev T, Buehler N, Hill D, Svendsen CN, Benvenisty N. The in vitro survival of human monosomies and trisomies as embryonic stem cells. Stem Cell Research. 9: 218-24. PMID 22892439 DOI: 10.1016/J.Scr.2012.07.002 |
0.444 |
|
| 2012 |
Ben-David U, Kopper O, Benvenisty N. Expanding the boundaries of embryonic stem cells. Cell Stem Cell. 10: 666-77. PMID 22704506 DOI: 10.1016/J.Stem.2012.05.003 |
0.475 |
|
| 2012 |
Fishman B, Segev H, Kopper O, Nissenbaum J, Schulman M, Benvenisty N, Itskovitz-Eldor J, Kitsberg D. Targeting pancreatic progenitor cells in human embryonic stem cell differentiation for the identification of novel cell surface markers. Stem Cell Reviews. 8: 792-802. PMID 22592939 DOI: 10.1007/S12015-012-9363-X |
0.536 |
|
| 2012 |
Bar-Nur O, Caspi I, Benvenisty N. Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. Journal of Molecular Cell Biology. 4: 180-3. PMID 22430918 DOI: 10.1093/Jmcb/Mjs007 |
0.419 |
|
| 2012 |
Ben-David U, Benvenisty N. High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells (Dayton, Ohio). 30: 612-22. PMID 22328490 DOI: 10.1002/Stem.1057 |
0.444 |
|
| 2012 |
Kopper O, Benvenisty N. Stepwise differentiation of human embryonic stem cells into early endoderm derivatives and their molecular characterization. Stem Cell Research. 8: 335-45. PMID 22286009 DOI: 10.1016/J.Scr.2011.12.006 |
0.579 |
|
| 2012 |
Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Erattum: Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells (Cell Stem Cell (2011) 9 (17-23)) Cell Stem Cell. 11: 854. DOI: 10.1016/j.stem.2012.11.007 |
0.427 |
|
| 2012 |
Ben-David U, Mayshar Y, Benvenisty N. Significant acquisition of chromosomal aberrations in human adult mesenchymal stem cells: Response to Sensebé et al Cell Stem Cell. 10: 10-11. DOI: 10.1016/J.Stem.2011.12.007 |
0.407 |
|
| 2011 |
Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, Benvenisty N, Ben-Yosef D, Biancotti JC, Bosman A, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature Biotechnology. 29: 1132-44. PMID 22119741 DOI: 10.1038/Nbt.2051 |
0.497 |
|
| 2011 |
Ben-David U, Mayshar Y, Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell. 9: 97-102. PMID 21816361 DOI: 10.1016/J.Stem.2011.06.013 |
0.533 |
|
| 2011 |
Biancotti JC, Benvenisty N. Aneuploid human embryonic stem cells: origins and potential for modeling chromosomal disorders. Regenerative Medicine. 6: 493-503. PMID 21749207 DOI: 10.2217/Rme.11.27 |
0.451 |
|
| 2011 |
Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell. 9: 17-23. PMID 21726830 DOI: 10.1016/J.Stem.2011.06.007 |
0.532 |
|
| 2011 |
Goldring CE, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, French N, Hanley NA, Kelly L, Kitteringham NR, Kurth J, Ladenheim D, Laverty H, McBlane J, Narayanan G, et al. Assessing the safety of stem cell therapeutics. Cell Stem Cell. 8: 618-28. PMID 21624806 DOI: 10.1016/J.Stem.2011.05.012 |
0.363 |
|
| 2011 |
Stelzer Y, Yanuka O, Benvenisty N. Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells. Nature Structural & Molecular Biology. 18: 735-41. PMID 21572443 DOI: 10.1038/Nsmb.2050 |
0.54 |
|
| 2011 |
Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nature Reviews. Cancer. 11: 268-77. PMID 21390058 DOI: 10.1038/Nrc3034 |
0.554 |
|
| 2011 |
Sharon N, Mor I, Golan-lev T, Fainsod A, Benvenisty N. Molecular and functional characterizations of gastrula organizer cells derived from human embryonic stem cells. Stem Cells (Dayton, Ohio). 29: 600-8. PMID 21328508 DOI: 10.1002/Stem.621 |
0.514 |
|
| 2011 |
Knoppers BM, Isasi R, Benvenisty N, Kim OJ, Lomax G, Morris C, Murray TH, Lee EH, Perry M, Richardson G, Sipp D, Tanner K, Wahlström J, de Wert G, Zeng F. Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the International Stem Cell Forum Ethics Working Party. Stem Cell Reviews. 7: 482-4. PMID 21279481 DOI: 10.1007/S12015-010-9226-2 |
0.439 |
|
| 2011 |
Bruck T, Benvenisty N. Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Research. 6: 187-93. PMID 21276761 DOI: 10.1016/J.Scr.2010.12.001 |
0.454 |
|
| 2011 |
Mayshar Y, Yanuka O, Benvenisty N. Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells. Journal of Cellular and Molecular Medicine. 15: 1393-401. PMID 20561110 DOI: 10.1111/J.1582-4934.2010.01105.X |
0.449 |
|
| 2010 |
Ben-David U, Benvenisty N, Mayshar Y. Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle (Georgetown, Tex.). 9: 4603-4. PMID 21099357 DOI: 10.4161/Cc.9.23.14094 |
0.485 |
|
| 2010 |
Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 7: 521-31. PMID 20887957 DOI: 10.1016/J.Stem.2010.07.017 |
0.527 |
|
| 2010 |
Ellis J, Baum C, Benvenisty N, Mostoslavsky G, Okano H, Stanford WL, Porteus M, Sadelain M. Benefits of utilizing gene-modified iPSCs for clinical applications. Cell Stem Cell. 7: 429-30. PMID 20887948 DOI: 10.1016/J.Stem.2010.09.010 |
0.447 |
|
| 2010 |
Biancotti JC, Narwani K, Buehler N, Mandefro B, Golan-Lev T, Yanuka O, Clark A, Hill D, Benvenisty N, Lavon N. Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells (Dayton, Ohio). 28: 1530-40. PMID 20641042 DOI: 10.1002/Stem.483 |
0.413 |
|
| 2010 |
Urbach A, Bar-Nur O, Daley GQ, Benvenisty N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell. 6: 407-11. PMID 20452313 DOI: 10.1016/J.Stem.2010.04.005 |
0.463 |
|
| 2010 |
Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O, Dvorak P, Hovatta O, Otonkoski T, Tuuri T, Cui W, Brüstle O, ... ... Benvenisty N, et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nature Biotechnology. 28: 371-7. PMID 20351689 DOI: 10.1038/Nbt.1615 |
0.436 |
|
| 2010 |
Narwani K, Biancotti JC, Golan-Lev T, Buehler N, Hill D, Shifman S, Benvenisty N, Lavon N. Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening. In Vitro Cellular & Developmental Biology. Animal. 46: 309-16. PMID 20224970 DOI: 10.1007/S11626-010-9303-5 |
0.544 |
|
| 2010 |
Andrews PW, Benvenisty N, Knowles BB, McKay RD, Oh SK, Pera MF, Rossant J, Stacey GN. Human ES cell lines--introduction. In Vitro Cellular & Developmental Biology. Animal. 46: 167-8. PMID 20213278 DOI: 10.1007/S11626-010-9306-2 |
0.49 |
|
| 2010 |
Akopian V, Andrews PW, Beil S, Benvenisty N, Brehm J, Christie M, Ford A, Fox V, Gokhale PJ, Healy L, Holm F, Hovatta O, Knowles BB, Ludwig TE, et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cellular & Developmental Biology. Animal. 46: 247-58. PMID 20186512 DOI: 10.1007/S11626-010-9297-Z |
0.517 |
|
| 2010 |
Kopper O, Giladi O, Golan-Lev T, Benvenisty N. Characterization of gastrulation-stage progenitor cells and their inhibitory crosstalk in human embryoid bodies. Stem Cells (Dayton, Ohio). 28: 75-83. PMID 19921748 DOI: 10.1002/Stem.260 |
0.543 |
|
| 2009 |
Brevini TA, Pennarossa G, Antonini S, Paffoni A, Tettamanti G, Montemurro T, Radaelli E, Lazzari L, Rebulla P, Scanziani E, de Eguileor M, Benvenisty N, Ragni G, Gandolfi F. Cell lines derived from human parthenogenetic embryos can display aberrant centriole distribution and altered expression levels of mitotic spindle check-point transcripts. Stem Cell Reviews. 5: 340-52. PMID 20058199 DOI: 10.1007/S12015-009-9086-9 |
0.577 |
|
| 2009 |
Andrews PW, Arias-Diaz J, Auerbach J, Alvarez M, Ahrlund-Richter L, Baker D, Benvenisty N, Ben-Josef D, Blin G, Borghese L, Borstlap J, Bruce K, Brüstle O, Buckle R, Camby C, et al. Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research Purposes Stem Cell Reviews and Reports. 5: 301-314. PMID 20016957 DOI: 10.1007/S12015-009-9085-X |
0.529 |
|
| 2009 |
Blum B, Benvenisty N. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle (Georgetown, Tex.). 8: 3822-30. PMID 19887907 DOI: 10.4161/Cc.8.23.10067 |
0.702 |
|
| 2009 |
Pick M, Stelzer Y, Bar-Nur O, Mayshar Y, Eden A, Benvenisty N. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 27: 2686-90. PMID 19711451 DOI: 10.1002/Stem.205 |
0.55 |
|
| 2009 |
Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 5: 111-23. PMID 19570518 DOI: 10.1016/J.Stem.2009.06.008 |
0.561 |
|
| 2009 |
Straussman R, Nejman D, Roberts D, Steinfeld I, Blum B, Benvenisty N, Simon I, Yakhini Z, Cedar H. Developmental programming of CpG island methylation profiles in the human genome. Nature Structural & Molecular Biology. 16: 564-71. PMID 19377480 DOI: 10.1038/Nsmb.1594 |
0.601 |
|
| 2009 |
Blum B, Bar-Nur O, Golan-Lev T, Benvenisty N. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nature Biotechnology. 27: 281-7. PMID 19252483 DOI: 10.1038/Nbt.1527 |
0.736 |
|
| 2009 |
Urbach A, Benvenisty N. Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells. Plos One. 4: e4175. PMID 19137066 DOI: 10.1371/Journal.Pone.0004175 |
0.519 |
|
| 2009 |
Darr H, Benvenisty N. Genetic analysis of the role of the reprogramming gene LIN-28 in human embryonic stem cells. Stem Cells (Dayton, Ohio). 27: 352-62. PMID 19038789 DOI: 10.1634/Stemcells.2008-0720 |
0.57 |
|
| 2009 |
Benvenisty N, Skorecki K. ART, community, and beyond: Human embryonic stem cell research in Israel Kin, Gene, Community Reproductive Technologies Among Jewish Israelis. 19: 255-270. |
0.35 |
|
| 2008 |
Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Advances in Cancer Research. 100: 133-58. PMID 18620095 DOI: 10.1016/S0065-230X(08)00005-5 |
0.699 |
|
| 2008 |
Lavon N, Narwani K, Golan-Lev T, Buehler N, Hill D, Benvenisty N. Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells (Dayton, Ohio). 26: 1874-82. PMID 18450823 DOI: 10.1634/Stemcells.2008-0156 |
0.458 |
|
| 2008 |
Mayshar Y, Rom E, Chumakov I, Kronman A, Yayon A, Benvenisty N. Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal. Stem Cells (Dayton, Ohio). 26: 767-74. PMID 18192227 DOI: 10.1634/Stemcells.2007-1037 |
0.464 |
|
| 2007 |
Eiges R, Urbach A, Malcov M, Frumkin T, Schwartz T, Amit A, Yaron Y, Eden A, Yanuka O, Benvenisty N, Ben-Yosef D. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell. 1: 568-77. PMID 18371394 DOI: 10.1016/J.Stem.2007.09.001 |
0.489 |
|
| 2007 |
Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnology. 25: 803-16. PMID 17572666 DOI: 10.1038/Nbt1318 |
0.706 |
|
| 2007 |
Blum B, Benvenisty N. Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells (Dayton, Ohio). 25: 1924-30. PMID 17464084 DOI: 10.1634/Stemcells.2007-0073 |
0.717 |
|
| 2007 |
Daley GQ, Ahrlund Richter L, Auerbach JM, Benvenisty N, Charo RA, Chen G, Deng HK, Goldstein LS, Hudson KL, Hyun I, Junn SC, Love J, Lee EH, McLaren A, Mummery CL, et al. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science (New York, N.Y.). 315: 603-4. PMID 17272706 DOI: 10.1126/Science.1139337 |
0.575 |
|
| 2007 |
Dvash T, Sharon N, Yanuka O, Benvenisty N. Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. Stem Cells (Dayton, Ohio). 25: 465-72. PMID 17038673 DOI: 10.1634/Stemcells.2006-0179 |
0.568 |
|
| 2007 |
Lavon N, Benvenisty N. Part B: Directed Differentiation of Human Embryonic Stem Cells into Hepatic Cells Human Embryonic Stem Cells: the Practical Handbook. 187-194. DOI: 10.1002/9780470511619.ch12b |
0.433 |
|
| 2006 |
Darr H, Benvenisty N. Human embryonic stem cells: the battle between self-renewal and differentiation. Regenerative Medicine. 1: 317-25. PMID 17465785 DOI: 10.2217/17460751.1.3.317 |
0.559 |
|
| 2006 |
Friedrich Ben-Nun I, Benvenisty N. Human embryonic stem cells as a cellular model for human disorders. Molecular and Cellular Endocrinology. 252: 154-9. PMID 16690205 DOI: 10.1016/J.Mce.2006.03.034 |
0.526 |
|
| 2006 |
Lavon N, Yanuka O, Benvenisty N. The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells (Dayton, Ohio). 24: 1923-30. PMID 16675598 DOI: 10.1634/Stemcells.2005-0397 |
0.557 |
|
| 2006 |
Darr H, Mayshar Y, Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development (Cambridge, England). 133: 1193-201. PMID 16501172 DOI: 10.1242/Dev.02286 |
0.568 |
|
| 2006 |
Darr H, Benvenisty N. Factors involved in self-renewal and pluripotency of embryonic stem cells. Handbook of Experimental Pharmacology. 1-19. PMID 16370322 DOI: 10.1007/3-540-31265-X_1 |
0.539 |
|
| 2006 |
Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E, Mandelboim O, Reisner Y, Benvenisty N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells (Dayton, Ohio). 24: 221-9. PMID 16109762 DOI: 10.1634/Stemcells.2005-0188 |
0.8 |
|
| 2005 |
Kopper O, Benvenisty N. Manipulation of the human genome in human embryonic stem cells. Stem Cell Reviews. 1: 145-50. PMID 17142849 DOI: 10.1385/Scr:1:2:145 |
0.521 |
|
| 2005 |
Lavon N, Benvenisty N. Study of hepatocyte differentiation using embryonic stem cells. Journal of Cellular Biochemistry. 96: 1193-202. PMID 16211581 DOI: 10.1002/Jcb.20590 |
0.533 |
|
| 2005 |
Andrews PW, Benvenisty N, McKay R, Pera MF, Rossant J, Semb H, Stacey GN. The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research. Nature Biotechnology. 23: 795-7. PMID 16003358 DOI: 10.1038/Nbt0705-795 |
0.534 |
|
| 2005 |
Andrews PW, Benvenisty N. Starting from building blocks: Tissue engineering using stem cells Current Opinion in Biotechnology. 16: 485-486. DOI: 10.1016/J.Copbio.2005.09.002 |
0.403 |
|
| 2004 |
Dvash T, Benvenisty N. Human embryonic stem cells as a model for early human development. Best Practice & Research. Clinical Obstetrics & Gynaecology. 18: 929-40. PMID 15582547 DOI: 10.1016/J.Bpobgyn.2004.06.005 |
0.47 |
|
| 2004 |
Dvash T, Mayshar Y, Darr H, McElhaney M, Barker D, Yanuka O, Kotkow KJ, Rubin LL, Benvenisty N, Eiges R. Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Human Reproduction (Oxford, England). 19: 2875-83. PMID 15375076 DOI: 10.1093/Humrep/Deh529 |
0.574 |
|
| 2004 |
Dhara SK, Benvenisty N. Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Research. 32: 3995-4002. PMID 15284332 DOI: 10.1093/Nar/Gkh746 |
0.496 |
|
| 2004 |
Urbach A, Schuldiner M, Benvenisty N. Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells (Dayton, Ohio). 22: 635-41. PMID 15277709 DOI: 10.1634/Stemcells.22-4-635 |
0.695 |
|
| 2004 |
Lavon N, Yanuka O, Benvenisty N. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation; Research in Biological Diversity. 72: 230-8. PMID 15270779 DOI: 10.1111/J.1432-0436.2004.07205002.X |
0.601 |
|
| 2004 |
Hornstein E, Benvenisty N. The "brainy side" of human embryonic stem cells. Journal of Neuroscience Research. 76: 169-73. PMID 15048914 DOI: 10.1002/Jnr.20034 |
0.736 |
|
| 2004 |
Drukker M, Benvenisty N. The immunogenicity of human embryonic stem-derived cells. Trends in Biotechnology. 22: 136-41. PMID 15036864 DOI: 10.1016/J.Tibtech.2004.01.003 |
0.767 |
|
| 2004 |
Drukker M, Katz G, Mandelboim O, Benvenisty N. Immunogenicity of Human Embryonic Stem Cells Handbook of Stem Cells. 1: 663-674. DOI: 10.1016/B978-012436643-5/50075-4 |
0.741 |
|
| 2003 |
Schuldiner M, Benvenisty N. Factors controlling human embryonic stem cell differentiation. Methods in Enzymology. 365: 446-61. PMID 14696364 DOI: 10.1016/S0076-6879(03)65031-7 |
0.716 |
|
| 2003 |
Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells (Dayton, Ohio). 21: 257-65. PMID 12743320 DOI: 10.1634/Stemcells.21-3-257 |
0.72 |
|
| 2003 |
Lavon N, Benvenisty N. Differentiation and genetic manipulation of human embryonic stem cells and the analysis of the cardiovascular system. Trends in Cardiovascular Medicine. 13: 47-52. PMID 12586438 DOI: 10.1016/S1050-1738(02)00199-8 |
0.571 |
|
| 2002 |
Eiges R, Benvenisty N. A molecular view on pluripotent stem cells. Febs Letters. 529: 135-41. PMID 12354626 DOI: 10.1016/S0014-5793(02)03191-5 |
0.558 |
|
| 2002 |
Goldstein RS, Drukker M, Reubinoff BE, Benvenisty N. Integration and differentiation of human embryonic stem cells transplanted to the chick embryo. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 225: 80-6. PMID 12203723 DOI: 10.1002/Dvdy.10108 |
0.743 |
|
| 2002 |
Schuldiner O, Shor S, Benvenisty N. A computerized database-scan to identify c-MYC targets. Gene. 292: 91-9. PMID 12119103 DOI: 10.1016/S0378-1119(02)00668-6 |
0.345 |
|
| 2002 |
Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 9864-9. PMID 12114532 DOI: 10.1073/Pnas.142298299 |
0.802 |
|
| 2002 |
Benvenisty N. Europe and the stem cell debate. Trends in Biotechnology. 20: 183. PMID 11943365 DOI: 10.1016/S0167-7799(02)01941-8 |
0.463 |
|
| 2001 |
Schuldiner M, Eiges R, Eden A, Yanuka O, Itskovitz-Eldor J, Goldstein RS, Benvenisty N. Induced neuronal differentiation of human embryonic stem cells. Brain Research. 913: 201-5. PMID 11549388 DOI: 10.1016/S0006-8993(01)02776-7 |
0.678 |
|
| 2001 |
Schuldiner O, Benvenisty N. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene. 20: 4984-94. PMID 11526483 DOI: 10.1038/Sj.Onc.1204459 |
0.401 |
|
| 2001 |
Eiges R, Schuldiner M, Drukker M, Yanuka O, Itskovitz-Eldor J, Benvenisty N. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Current Biology : Cb. 11: 514-8. PMID 11413002 DOI: 10.1016/S0960-9822(01)00144-0 |
0.81 |
|
| 2001 |
Eden A, Van Nedervelde L, Drukker M, Benvenisty N, Debourg A. Involvement of branched-chain amino acid aminotransferases in the production of fusel alcohols during fermentation in yeast. Applied Microbiology and Biotechnology. 55: 296-300. PMID 11341309 DOI: 10.1007/S002530000506 |
0.603 |
|
| 2000 |
Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 97: 11307-12. PMID 11027332 DOI: 10.1073/Pnas.97.21.11307 |
0.74 |
|
| 2000 |
Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H, Benvenisty N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Molecular Medicine (Cambridge, Mass.). 6: 88-95. PMID 10859025 DOI: 10.1007/Bf03401776 |
0.732 |
|
| 2000 |
Ben-Yosef T, Benvenisty N. Hereditary cancer and developmental abnormalities. Biology of the Neonate. 77: 1-11. PMID 10658824 DOI: 10.1159/000014188 |
0.348 |
|
| 1999 |
Eden A, Benvenisty N. Involvement of branched-chain amino acid aminotransferase (Bcat1/Eca39) in apoptosis. Febs Letters. 457: 255-61. PMID 10471790 DOI: 10.1016/S0014-5793(99)01054-6 |
0.366 |
|
| 1999 |
Ben-Porath I, Yanuka O, Benvenisty N. The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity. Molecular and Cellular Biology. 19: 3529-39. PMID 10207076 DOI: 10.1128/Mcb.19.5.3529 |
0.336 |
|
| 1998 |
Ben-Yosef T, Yanuka O, Halle D, Benvenisty N. Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene. 17: 165-71. PMID 9674700 DOI: 10.1038/Sj.Onc.1201939 |
0.384 |
|
| 1998 |
Eden A, Benvenisty N. Characterization of a branched-chain amino-acid aminotransferase from Schizosaccharomyces pombe Yeast. 14: 189-194. PMID 9483807 DOI: 10.1002/(Sici)1097-0061(19980130)14:2<189::Aid-Yea210>3.0.Co;2-V |
0.318 |
|
| 1998 |
Schuldiner O, Yanover C, Benvenisty N. Computer analysis of the entire budding yeast genome for putative targets of the GCN4 transcription factor. Current Genetics. 33: 16-20. PMID 9472075 DOI: 10.1007/S002940050303 |
0.316 |
|
| 1997 |
Levinson-Dushnik M, Benvenisty N. Involvement of hepatocyte nuclear factor 3 in endoderm differentiation of embryonic stem cells Molecular and Cellular Biology. 17: 3817-3822. PMID 9199315 DOI: 10.1128/Mcb.17.7.3817 |
0.553 |
|
| 1996 |
Cohen H, Trus M, Benvenisty N, Reshef L. Identification of differentially expressed genes during hepatocytes development and characterization of their prenatal hormonal induction European Journal of Biochemistry. 242: 550-556. PMID 9022681 DOI: 10.1111/J.1432-1033.1996.0550R.X |
0.66 |
|
| 1996 |
Ben-Porath I, Benvenisty N. Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins Gene. 183: 69-75. PMID 8996089 DOI: 10.1016/S0378-1119(96)00475-1 |
0.443 |
|
| 1996 |
Eden A, Simchen G, Benvenisty N. Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases Journal of Biological Chemistry. 271: 20242-20245. PMID 8702755 DOI: 10.1074/Jbc.271.34.20242 |
0.376 |
|
| 1996 |
Schuldiner O, Eden A, Ben-Yosef T, Yanuka O, Simchen G, Benvenisty N. ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. Proceedings of the National Academy of Sciences of the United States of America. 93: 7143-8. PMID 8692959 DOI: 10.1073/Pnas.93.14.7143 |
0.425 |
|
| 1995 |
Benvenisty N, Ornitz DM. BK1: An FGF-responsive central nervous system-derived cell line Growth Factors. 12: 49-55. PMID 8527163 DOI: 10.3109/08977199509003213 |
0.409 |
|
| 1995 |
Dushnik-Levinson M, Benvenisty N. Embryogenesis in vitro: Study of differentiation of embryonic stem cells Neonatology. 67: 77-83. PMID 7766734 DOI: 10.1159/000244147 |
0.541 |
|
| 1994 |
Yanuka-Kashles O, Cohen H, Trus M, Aran A, Benvenisty N, Reshef L. Transcriptional regulation of the phosphoenolpyruvate carboxykinase gene by cooperation between hepatic nuclear factors Molecular and Cellular Biology. 14: 7124-7133. PMID 7935427 DOI: 10.1128/Mcb.14.11.7124 |
0.645 |
|
| 1991 |
Benvenisty N, Reshef L. Regulation of tissue- and development-specific gene expression in the liver. Biology of the Neonate. 59: 181-9. PMID 2070019 DOI: 10.1159/000243341 |
0.674 |
|
| 1991 |
Shoshani T, Benvenisty N, Trus M, Reshef L. Cis -regulatory elements that confer differential expression upon the rat gene encoding phosphoenolpyruvate carboxykinase in kidney and liver Gene. 101: 279-283. PMID 2055492 DOI: 10.1016/0378-1119(91)90424-A |
0.665 |
|
| 1990 |
Trus M, Benvenisty N, Cohen H, Reshef L. Developmentally regulated interactions of liver nuclear factors with the rat phosphoenolpyruvate carboxykinase promoter Molecular and Cellular Biology. 10: 2418-2422. PMID 2325658 DOI: 10.1128/Mcb.10.5.2418 |
0.606 |
|
| 1990 |
Brandes R, Arad R, Benvenisty N, Weil S, Bar-Tana J. The induction of adipose conversion by bezafibrate in 3T3-L1 cells. Synergism with dibutyryl-cAMP Bba - Molecular Cell Research. 1054: 219-224. PMID 1976021 DOI: 10.1016/0167-4889(90)90244-8 |
0.319 |
|
| 1989 |
Benvenisty N, Nechushtan H, Cohen H, Reshef L. Separate cis-regulatory elements confer expression of phosphoenolpyruvate carboxykinase (GTP) gene in different cell lines Proceedings of the National Academy of Sciences of the United States of America. 86: 1118-1122. PMID 2919162 DOI: 10.1073/Pnas.86.4.1118 |
0.671 |
|
| 1989 |
Benvenisty N, Shoshani T, Farkash Y, Soreq H, Reshef L. trans activation of rat phosphoenolpyruvate carboxykinase (GTP) gene expression by micro-coinjection of rat liver mRNA in Xenopus laevis oocytes. Molecular and Cellular Biology. 9: 5244-7. PMID 2601721 DOI: 10.1128/Mcb.9.11.5244 |
0.617 |
|
| 1987 |
Nechushtan H, Benvenisty N, Brandeis R, Reshef L. Glucocorticoids control phosphoenolpyruvate carboxykinase gene expression in a tissue specific manner Nucleic Acids Research. 15: 6405-6417. PMID 3627993 DOI: 10.1093/Nar/15.16.6405 |
0.62 |
|
| 1987 |
Benvenisty N, Reshef L. Developmental expression and modification of genes Neonatology. 52: 61-69. PMID 3307929 DOI: 10.1159/000242685 |
0.63 |
|
| 1987 |
Benvenisty N, Reshef L. Developmental acquisition of DNase I sensitivity of the phosphoenolpyruvate carboxykinase (GTP) gene in rat liver. Proceedings of the National Academy of Sciences of the United States of America. 84: 1132-6. PMID 3029767 DOI: 10.1073/Pnas.84.5.1132 |
0.622 |
|
| 1987 |
Cohen H, Benvenisty N, Reshef L. Fate of polyoma origin of replication after its direct introduction into mice Febs Letters. 223: 347-351. PMID 2822492 DOI: 10.1016/0014-5793(87)80317-4 |
0.567 |
|
| 1986 |
Benvenisty N, Reshef L. Direct introduction of genes into rats and expression of the genes Proceedings of the National Academy of Sciences of the United States of America. 83: 9551-9555. PMID 3540943 DOI: 10.1073/Pnas.83.24.9551 |
0.629 |
|
| 1985 |
Cohen H, Gidoni B, Shouval D, Benvenisty N, Mencher D, Meyuhas O, Reshef L. Conservation from rat to human of cytosolic phosphoenolpyruvate carboxykinase and the control of its gene expression Febs Letters. 180: 175-180. PMID 2981716 DOI: 10.1016/0014-5793(85)81066-8 |
0.618 |
|
| 1985 |
Benvenisty N, Mencher D, Meyuhas O, Razin A, Reshef L. Sequential changes in DNA methylation patterns of the rat phosphoenolpyruvate carboxykinase gene during development Proceedings of the National Academy of Sciences of the United States of America. 82: 267-271. PMID 2578665 DOI: 10.1073/Pnas.82.2.267 |
0.632 |
|
| 1985 |
Benvenisty N, Szyf M, Mencher D, Razin A, Reshef L. Tissue-specific hypomethylation and expression of rat phosphoenolpyruvate carboxykinase gene induced by in vivo treatment of fetuses and neonates with 5-azacytidine Biochemistry. 24: 5015-5019. PMID 2416339 DOI: 10.1021/Bi00340A009 |
0.628 |
|
| 1984 |
Mencher D, Cohen H, Benvenisty N, Meyuhas O, Reshef L. Primary activation of cytosolic phosphoenolpyruvate carboxykinase gene in fetal rat liver and the biogenesis of its mRNA European Journal of Biochemistry. 141: 199-203. PMID 6723657 DOI: 10.1111/J.1432-1033.1984.Tb08175.X |
0.589 |
|
| 1983 |
Benvenisty N, Simchon EB, Cohen H, Mencher D, Meyuhas O, Reshef L. Control of the activity of phosphoenolpyruvate carboxykinase and the level of its mRNA in livers of newborn rats. Effect of diabetes, glucose load and glucocorticoids European Journal of Biochemistry. 132: 663-668. PMID 6343080 DOI: 10.1111/J.1432-1033.1983.Tb07416.X |
0.566 |
|
| Show low-probability matches. |
